Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases

Rheumatology

Volumn 47, Issue 2, 2008, Pages 165-171

  Schild Poulter, C ^a,b   Su, A ^a   Shih, A ^a   Kelly, O P ^c   Fritzler, M J ^d   Goldstein, R ^a,d   Hache R J G ^a,e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Autoantibody association; Autoantigen; Autoimmunity; DNA damage; Ku

Indexed keywords

AUTOANTIBODY; DNA DEPENDENT PROTEIN KINASE; KU ANTIGEN; MRE11 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; WERNER SYNDROME PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASES; DNA REPAIR; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; RECOMBINANT PROTEINS; RHEUMATIC DISEASES;

EID: 38649108514     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem338     Document Type: Article

References (50)

1. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
2. Lyons R, Narain S, Nichols C, Satoh M, Reaves WH. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann NY Acad Sci 2005;1050:217-28.
3. D'Cruz D. Testing for autoimmunity in humans. Toxicol Lett 2002;127:93-100.
4. Ho K, Reveille J. The clinical relevance of autoantibodies in sclerodenma. Arthritis Res Ther 2003;5:80-93.
5. Lee K-J, Dong X, Wang J, Takeda Y, Dynan WS. Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region. J Immunol 2002;169:3413-21.
6. McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol 2002;168:2054-62.
7. Monestier M. Autoantibodies to nucleosomes and histone-DNA complexes. Methods 1997;11:36-43.
8. Migliorini P, Baldini C, Rocchi V, Bombardleri S, Anti-Sm and anti-RNP antibodies. Autoimmunity 2005;38:47-54.
9. Utz PJ, Hottelet M, van Venrooij WJ, Anderson P. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death. J Exp Med 1998;187:547-60.
10. Hof D, Raats JM, Pruijn GJ. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen. Autoimmun Rev 2005;4:380-8.
11. Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Res 200;2:101-14.
12. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981;68:611-20.
13. Mimori T. Clinical significance of anti=Ku autoantibodies a serologic marker of overlap syndrome? Intern Med 2002;41:1096-8.
14. Cooley HM, Melny BJ, Gleeson R, Greco T, Kay TW. Clinical and serological associations of anti-Ku antibody. J Rheumatol 1999;26:563-7.
15. Takeda Y, Dynan WS. Autoantibodies againet DNA double-strand break repair proteins. Front Biosci 2001;6:D1412-22.
16. Reeves WH. Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:391-414.
17. Lieber MR, Ma Y, Pannicke U, Schwarz K. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair 2004;3:817-26.
18. Schild-Poulter P, Hache RJG, Soubeyrand S. Ku antigen: A versatile DNA binding protein with multiple cellular functions. In: Parisi V, De Fonzo V, Aluffi-Pentini F, eds. Dynamical Genetics, Research Signpost, 2004:257-84.
19. Meek K, Gupta S, Ramadan DA, Lees-Miller SP. The DNA-dependent protein kinase: The director at the end. Immunol Rev 2004;132-41.
20. Mari P-O, Florea BI, Persengiev SP et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl-Acad Sci USA 2006;103:18597-602.
21. Comal L, Li B. The Wemer syndrome protein at the crossroads of DNA repair and apoptosis. Mech Ageing Dev 2004;125:521-8.
22. Li B, Cornai L. Requirements for the nucleolytic processing of DNA ends by the Wemer syndrome protein-Ku70/80 complex. J Biol Chem 2001;276: 9896-902.
23. Cooper MP, Machwe A, Orren DK, Brosh RM, Ramsden D, Bohr VA. Ku complex interacts with and stimulates the Werner protein. Genes Dev 2000;14:907-12.
24. Vidakovic M, Poznanovic G, Bode J. DNA break repair: Refined rules of an already complicated game. Biochem Cell Biol 2005;83:365-73.
25. Goadecke W, Eijpe M, Offenberg HH, van Aalderan M, Heying C. Mre11 and Ku70 interact in somatic cells, but are differentially expressed in early meiosis. Nat Genet 1999;23:194-8.
26. Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA. Association of DNA polymerase mu (poll mu) with Ku and ligase IV: Role for pol mu in end-joining double-strand break repair. Mol Cell Biol 2002;22:5194-202.
27. Suwa A, Hirakata M, Takeda Y et al. Autoantibodies to DNA-dependent protein kinase. J Clin Invest 1996;97:1417-1421.
28. Satoh M, Ajmani AK, Stojanov L et al. Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA-dependent protein kinase catalytic subunit. Clin Exp Immunol 1996;105,460-7.
29. Amett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythemastesus. Arthritis Rheum 1982;25:1271-7.
31. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
32. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
33. Vitali C, Bombardleri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
34. Nishimaki T, Aotsuka S, Kunieda T, Yokohari R. Preliminary criteria for the diagnosis of pulmonary hypertension in mixed connective tissue disease. Ryumachi 1991;31:159-66.
35. Mosca M. Neri R. Bombardieri S. Undifferentiated connective tissue diseases (UCTD): A review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999;17:615-20.
36. Schild-Poulter C, Pope L, Giffin W et al. The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase. J Biol Chem 2001;276:16848-56.
37. Desai-Mehta A, Cerosaletti KM, Concannon P. Distinct functional domains of nibrin mediate, Mre11 binding, focus, formation, and nuclear localization. Mol Cell Biol 2001;21:2184-91.
38. Reeves WH, Pierani A, Chou CH et al. Epitopes of the p70 and p80 (Ku) lupus autoantigens. J Immunol Methods 1991;146:2678-86.
39. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004;34:501-37.
40. Franceschini F, Cavazzana I, Generali D et al. Anti-Ku antibodies in connective tissue diseases: Clinical and serological evaluation of 14 patients. J Rheumatol 2002;29:1393-7.
41. Jafri F, Hardin JA, Dynan WS. A method to detect particle-specific antibodies against Ku and the DNA-dependent protein kinase catalytic subunit in autoimmune sera. J Immunol Methods 2001;251:53-61.
42. Wang J, Dong X, Stojanov L, Kimpel D, Satoh M, Reeves WH. Human autoantibodies stabilize the quaternary structure of Ku antigen. Arthritis Rheum 1997;40:1344-53.
43. Kamachi M, Le TM, Kim SJ, Geiger ME, Anderson P, Utz PJ. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. J Exp Med 2002;196:1213-25.
44. Huang J, Dynan WS. Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/ Rad50NBS1-containing fraction. Nucleic Acids Res 2002;30:667-74.
45. Chen L, Trujillo K, Ramos W, Sung P, Tomkinson AE. Promotion of Dn14-Catalyzed DNA end-joining by the Rad50/Mre11/Xrs2 and Hdf1/Hdf2 complexes. Mol Cell 2001;8:1105-15.
46. Casciola-Rosen LA, Pluta AF, Plotz PH et al. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum 2001;44:389-96.
47. Lai FPL, Tsukada Y, Ichikawa H, Dunster K, Sentry JW, Toh B-H. Autoantibody to DNA excision repair enzyme hMYH in a patient with rheumatic disease. Clin Immunol 2001;99:291-7.
48. Mansoor F, Ali A, Ali R. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin. Autoimmunity 2005;38:431-8.
49. Henriksson G, Brant M, Sallmyr A, Fukushima S, Manthorpe R, Bredberg A. Enhanced DNA damage-induced p53 peptide phosphorylation and cell-cycle arrest in Sjogren's syndrome cells. Eur J Clin Invest 2002;32:458-65.
50. McCurdy D, Tai LQ, Frias S, Wang Z. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiat Res 1997;147:48-54.